heart

The field of cardiology is rapidly evolving, driven by advances in drugs and technologies that have the potential to improve the cardiovascular care of their patients. Digital health tools connect primary care providers with cardiologists, help patients better communicate with their provider and use health information to manage their care.  However, with these improvements come challenges as cardiologists and their care teams work to stay current with the therapeutic advances, field questions from their patients, and analyze an exploding volume of data available to improve the quality of care. The Cardiology Education Hub aims to provide the education, resources, and access to digital health tools necessary to meet these challenges.

CME/CE Learning Activities

Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

Participate Now

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. This CME Outfitters OnDemand webcast features expert faculty addressing the impact of undiagnosed NVAF, the benefit and use of screening tools for early detection, best practices for optimizing screening, implementing oral anticoagulant therapy for stroke prevention, and the use of digital health technologies, with a goal of fostering collaborative care and optimizing patient outcomes.

Getting to the Heart of the Underdiagnosis and Undertreatment of Non-valvular Atrial Fibrillation: Integrating Optimal Screening, Team-Based Care and Digital Health Tools in Primary Care Settings

Participate Now

With the increasing age of the U.S. population, the “perceived” incidence of atrial fibrillation (AF) – the most common arrhythmia in clinical practice and a leading cause of morbidity and mortality – is increasing. However, patients may not notice symptoms that warrant care-seeking, which leads to physicians not having an index of suspicion relative to those at high risk for AF. Because AF is a major risk factor for thromboembolic disease and can lead to an increased risk for stroke, increased screening and use of anticoagulation treatment can help high-risk patients avoid these events. Note: Credit Is No Longer Available

Identifying High-Risk Patients for Non-Valvular Atrial Fibrillation in Community Practices

Participate Now

Increased screening and use of anticoagulation treatment can help high-risk patients and likely decrease the number of patients who are not diagnosed with AF until they have had an AF-related stroke.

In this CME Outfitters OnDemand, expert faculty address the impact of underdiagnosed NVAF and the benefits and uses of screening tools and appropriate implementation of oral anticoagulant therapy. Note: Credit Is No Longer Available

Tools and Techniques to Screen for Non-Valvular Atrial Fibrillation in Primary Care Settings

Participate Now

As 20% or more of patients who have an atrial fibrillation (AF)-related stroke are not diagnosed until the time of stroke or shortly thereafter, it is important for clinicians to implement both opportunistic and systematic screening in primary care settings to reduce the risk of stroke and death. These screening tactics have been shown to be effective in detecting NVAF, yet clinicians are challenged in understanding the tools available and strategies for implementing them.
Given these challenges, in this CME Outfitters OnDemand, expert faculty discuss these screening techniques and how best to incorporate them to increase early detection of NVAF, which will lead to implementation of care that will then reduce the risk of stroke and death. Note: Credit Is No Longer Available

Best Practices for the Use of Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation

Participate Now

The early use of oral anticoagulants in eligible patients with non-valvular atrial fibrillation (NVAF) has resulted in reduced stroke rates. Clinicians often fail to implement guideline-concordant care due to lack of awareness of patients who could benefit from therapy, fears regarding bleeding, or lack of confidence in utilizing these therapies in primary care settings. In this CME Outfitters On Demand featuring real-world best practices and data, expert faculty focus on appropriate implementation of oral anticoagulant therapy in patients with NVAF for stroke prevention. Note: Credit Is No Longer Available

Sealing the Gaps in Non-Valvular Atrial Fibrillation Care: Use of Digital Tools to Optimize Treatment and Reduce Costs

Participate Now

When treating non-valvular atrial fibrillation (NVAF), the importance of tools that can engage patients in their own care should not be overlooked. Digital health tools such as digital coaching and use of e-consults help foster shared decision-making and facilitate collaborative care strategies, thus optimizing treatment outcomes and costs. In this CME Outfitters On Demand, expert faculty explore digital tools and the data that support them showing their impact on outcomes and costs, as well as reviewing best practice models that clinicians can use. Note: Credit Is No Longer Available

Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction

Participate Now!

Free CME/CE certified webcast
Note: Credit Is No Longer Available

Collaborative Care Strategies for Reducing Hospital Readmissions in Patients with Heart Failure with Reduced Ejection Fraction

Participate Now!

Free CME/CE certified webcast
Note: Credit Is No Longer Available

The Role of Pharmacists in Helping Patients Navigate Their Treatment Course: Best Practices from Catalyst Health Network

Participate Now!

Free CME/CE certified webcast
Resources for Patients
What Is AFib? A Virtual Whiteboarding Session
An estimated 2.3 million adults in the US have AFib, and this number is projected to increase to 5.6 million by 2050. Learn more about atrial fibrillation and non-valvular atrial fibrillation in this informative virtual “whiteboarding session”.

Questions to Ask Your Healthcare Provider

Patient Education – Medications and Procedures for AFib